Skip to Content

Ropivacaine Injection

Last Updated: July 20, 2018
Status: Current

Products Affected - Description
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 25 count, NDC 63323-0288-21
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0285-65
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL premixed bag, 1 count, NDC 63323-0285-61
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 25 count, NDC 63323-0285-23
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0285-64
    • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0287-20
    • Ropivacaine injection, Akorn, 5 mg/mL, 30 mL vial, 1 count, NDC 17478-0081-30
    • Ropivacaine injection, AuroMedics, 10 mg/mL, 10 mL vial, 25 count, NDC 55150-0200-10
    • Ropivacaine injection, AuroMedics, 10 mg/mL, 20 mL vial, 25 count, NDC 55150-0201-20
    • Ropivacaine injection, AuroMedics, 2 mg/mL, 100 mL infusion bottle, 25 count, NDC 55150-0196-99
    • Ropivacaine injection, AuroMedics, 2 mg/mL, 20 mL vial, 25 count, NDC 55150-0195-20
    • Ropivacaine injection, Pfizer, 10 mg/mL, 10 mL vial, 10 count, NDC 00409-9303-10
    • Ropivacaine injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-9300-10
    • Ropivacaine injection, Pfizer, 5 mg/mL, 30 mL vial, 10 count, NDC 00409-9301-30
    • Ropivacaine injection, Pfizer, 7.5 mg/mL, 20 mL vial, 10 count, NDC 00409-9302-20
Reason for the Shortage
    • Akorn has ropivacaine on shortage due to increased demand.
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi has Naropin on shortage due to increased demand and manufacturing delays.
    • Pfizer has ropivacaine on shortage due to manufacturing delays.
Available Products
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0288-10
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 25 count, NDC 63323-0288-11
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0288-20
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0285-10
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 25 count, NDC 63323-0285-13
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0285-20
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL premixed bag, 1 count, NDC 63323-0285-63
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0286-00
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0286-20
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL vial, 25 count, NDC 63323-0286-23
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0286-63
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL Steripak plastic ampule, 5 count, NDC 63323-0286-31
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL vial, 25 count, NDC 63323-0286-35
    • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL vial, 25 count, NDC 63323-0287-21
    • Ropivacaine injection, AuroMedics, 5 mg/mL, 20 mL vial, 25 count, NDC 55150-0197-20
    • Ropivacaine injection, AuroMedics, 5 mg/mL, 30 mL vial, 25 count, NDC 55150-0198-30
    • Ropivacaine injection, AuroMedics, 7.5 mg/mL, 20 mL vial, 25 count, NDC 55150-0199-20
    • Ropivacaine injection, Pfizer, 10 mg/mL, 20 mL vial, 10 count, NDC 00409-9303-20
    • Ropivacaine injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-9300-20

Estimated Resupply Dates

    • Akorn has ropivacaine 2 mg/mL 30 mL vials on allocation.
    • AuroMedics has ropivcaine 2 mg/mL 20 mL vials and 100 mL bottles and 10 mg/mL 10 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Pfizer has ropivacaine 2 mg/mL 10 mL vials on back order and the company estimates a release date of October 2018. The 5 mg/mL 30 mL vials are available in limited supply. The 7.5 mg/mL 20 mL vials are on back order and the company estimates a release date of July 2018. The 10 mg/mL 10 mL vials are on back order and the company estimates a release date of September 2018.
    • Fresenius Kabi has Naropin 2 mg/mL 100 mL and 200 mL bottles on back order and the company estimates a release date of late-July 2018. The 2 mg/mL 20 mL vials are on back order and the company estimates a release date of late-July to early-August 2018. The 5 mg/mL 30 mL Steripak ampules are on back order and the company estimates a release date of 3rd quarter 2018. The 7.5 mg/mL 20 mL Steripak ampules are on back order and the company estimates a release date of late-July 2018. The 10 mg/mL 20 mL vials are on back order and the company estimates a release date of late-July to early-August 2018. Check wholesalers for inventory.

Updated

Updated July 20, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide